Nifuratel is primarily used as an antimicrobial agent, particularly effective against a range of bacterial, fungal, and protozoal infections. It is commonly prescribed for the treatment of gynecological infections, including vaginitis caused by Trichomonas vaginalis, Candida species, and mixed bacterial infections. Its broad-spectrum activity makes it a versatile option in managing urogenital infections, helping to alleviate symptoms and eradicate pathogens.

In addition to gynecological applications, Nifuratel is also utilized in the treatment of urinary tract infections (UTIs), where it targets both gram-positive and gram-negative bacteria. Its efficacy in combating resistant strains of microorganisms has made it a valuable component in therapeutic regimens, especially in cases where other antibiotics may be less effective.

Nifuratel is often administered orally or topically, depending on the type and severity of the infection. Its ability to act locally at the site of infection ensures targeted treatment with minimal systemic side effects. This makes it a preferred choice for patients requiring safe and effective management of infections in sensitive areas.